Background and aims There are increasing case reports of rhino-orbital mucormycosis in
people with coronavirus disease 2019 (COVID-19), especially from India. Diabetes mellitus …

Reports of COVID-19-associated mucormycosis have been increasing in frequency since
early 2021, particularly among patients with uncontrolled diabetes. Patients with diabetes …

Purpose: COVID-19-associated rhino-orbital-cerebral mucormycosis (ROCM) has reached
epidemic proportion during India's second wave of COVID-19 pandemic, with several risk …

In its wake, the COVID‐19 pandemic has ushered in a surge in the number of cases of
mucormycosis. Most cases are temporally linked to COVID‐19; hence, the entity is described …

Fungal pathogens cause more than a billion human infections every year, resulting in more
than 1.6 million deaths annually. Understanding the natural history and evolutionary ecology …

The Indian Council of Medical Research released guidelines for the screening, diagnosis,
and management of mucormycosis in patients with COVID-19. 3 The most common causes …

The pandemic of coronavirus disease 2019 (COVID-19) still remains on an upsurge trend.
The second wave of this disease has led to panic in many countries, including India and …

Background The recent emergence of the Coronavirus Disease (COVID-19) disease had
been associated with reports of fungal infections such as aspergillosis and mucormycosis …

Reports are increasing on the emergence of COVID‐19–associated mucormycosis (CAM)
globally, driven particularly by low‐and middle‐income countries. The recent unprecedented …

Abstract Importance Coronavirus disease (COVID‐19) causes an immunosuppressed state
and increases risk of secondary infections like mucormycosis. We evaluated clinical …